Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma
The addition of cobimetinib to vemurafenib was associated with a significant improvement in progression-free survival among patients with BRAF V600-mutated metastatic melanoma, ...